CXCL12 and neoplasm: We found that animals bearing the human tumor cell lines treated with neutralizing anti-CXCL12 antibodies resulted in markedly reduced metastases to the lungs, adrenal glands, liver and circulation (buffy coat), as compared to control antibody treated groups (Fig. 6).